Krajina: Nový Zéland
Jazyk: angličtina
Zdroj: Medsafe (Medicines Safety Authority)
Hydrocortisone 0.5%{relative};
iNova Pharmaceuticals (New Zealand) Limited
Hydrocortisone 0.5% w/w
0.5 %
Topical cream
Active: Hydrocortisone 0.5%{relative} Excipient: Cetomacrogol 1000 Cetostearyl alcohol Chlorocresol Dibasic sodium phosphate Liquid paraffin Phosphonic acid Purified water Sodium hydroxide White soft paraffin
Tube, aluminium, 15g, 15 g
Pharmacy only
Pharmacy only
Pharmacia & Upjohn Company LLC
Package - Contents - Shelf Life: Tube, aluminium, - 15 g - 24 months from date of manufacture stored at or below 25°C - Tube, aluminium, - 30 g - 24 months from date of manufacture stored at or below 25°C
1981-12-02
DATA SHEET SKINCALM _HYDROCORTISONE 1% W/W _ PRESENTATION A white, smooth cream with the odour of chlorocresol. USES _ACTIONS _ When applied topically hydrocortisone acetate is primarily effective because of its anti-inflammatory, anti-pruritic and vasoconstrictive actions. _PHARMACOKINETICS _ Hydrocortisone is absorbed through the skin, particularly in denuded areas. Hydrocortisone is metabolised in the liver and most body tissues to hydrogenated and degraded forms such as tetrahydrocortisone and tetrahydrocortisol. These are excreted in the urine, mainly conjugated as glucuronides, together with a very small proportion of unchanged hydrocortisone. When administered by topical application, particularly under an occlusive dressing or when the skin is broken, sufficient corticosteroid may be absorbed to give systemic effects. INDICATIONS For contact dermatitis from allergies or irritants and for skin reactions to insect bites. DOSAGE AND ADMINISTRATION Use sparingly on a small area, once or twice a day, for a maximum of 7 days. CONTRAINDICATIONS Skin lesions caused by infection with viruses (eg herpes, chickenpox), perioral dermatitis, rosacea, fungal skin infections (eg candidiasis, tinea) and ulcerative conditions. Hypersensitivity to any of the ingredients. WARNINGS AND PRECAUTIONS Should hypersensitivity occur, application should be stopped immediately. This preparation is not to be used in the eye, as there is a potential risk of glaucoma and cataract. Co-existing infection may require specific antibiotics or withdrawal of therapy. Babies and children up to four years should not be treated with dermal steroids for longer than three weeks. In infants the napkin may act as an occlusive dressing and increase absorption. Adrenal suppression is more likely to occur in infants and children. Do not use in children under 2 years of age without medical advice. Systemic absorption resulting in adrenal suppression may occur especially under occlusion with weekly doses of over 50 g, 30 g and 15 g of respectively mild to Prečítajte si celý dokument